Studies on a leukocytosis-inducing antibiotic agent, Marimycin.
D000328:Adult; D000368:Aged; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003036:Cobalt Isotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D007962:Leukocytes / Q000187:drug effects; D007964:Leukocytosis / Q000139:chemically induced*; D007970:Leukopenia / Q000139:chemically induced; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000532:radiotherapy; D008297:Male; D008441:Maxillary Neoplasms / Q000532:radiotherapy; D008545:Melanoma / Q000532:radiotherapy; D051379:Mice; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy; D011817:Rabbits; D011837:Radiation-Protective Agents; D013945:Thymoma / Q000532:radiotherapy; D014062:Tongue Neoplasms / Q000532:radiotherapy; D014067:Tonsillar Neoplasms / Q000532:radiotherapy; D014594:Uterine Neoplasms / Q000532:radiotherapy
D000903:Antibiotics, Antineoplastic; D003036:Cobalt Isotopes; D011837:Radiation-Protective Agents